MAYA VALENTIN: Open Payments
NPI 1295453454 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 17 payments from 9 companies in 2025. Trend: 2023 $18 · 2024 $229 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 4 | $104 |
| Exeltis, USA Inc. | 4 | $84 |
| MILLICENT US INC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $27 |
| Novo Nordisk Inc | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Organon LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: ZURZUVAE, SLYND, FEMLYV, Veozah, Wegovy, COMIRNATY, Mirena, Kyleena.
Industry payments across NY — which companies pay providers there.
